I migliori medici di Immunoterapia per il tumore al polmone in Israele — TOP-4 medici

Il Prof. Merimsky dirige l'Unità di Oncologia dei Tessuti Molli e delle Ossa presso il Sourasky Medical Center, con oltre 40 anni di esperienza nella ricerca e nel trattamento dell'immunoterapia per il cancro del polmone.

• Specializzato in protocolli di immunoterapia per casi avanzati di cancro del polmone
• Membro della facoltà ESMO per il sarcoma e l'oncologia toracica
• Ex Presidente della Società di Oncologia e Radioterapia di Israele
• Autore di oltre 50 articoli di ricerca sull'immunologia tumorale e sulle terapie mirate

Ricercatore leader nell'immunoterapia per il cancro al polmone – Il Dr. Raphael è pioniere negli studi sul sequenziamento del repertorio delle cellule T presso il Sourasky Medical Center.

• Ricercatore principale per numerosi studi clinici sull'immunoterapia nel NSCLC
• Moderatore del Molecular Tumor Board per la Società Israeliana di Oncologia del Polmone
• Specializzato in profilazione genomica e tecniche di biopsia liquida
• Onorato come insegnante eccezionale presso l'Università di Tel Aviv
• Membro delle società oncologiche IASLC ed ESMO

Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.

He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.

Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.

Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.

He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.

He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.